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Abstract
Introduction: Mesenchymal stem (stromal) cells (MSCs) possess self-renewal, differentiation and immunoregulatory
properties, and therefore are being evaluated as cellular therapy for inflammatory and autoimmune diseases, and
for tissue repair. MSCs isolated from bone marrow are extensively studied. Besides bone marrow, MSCs have been
identified in almost all organs of the body including the lungs. Lung-derived MSCs may be more effective as
therapy for lung diseases as compared to bone marrow-derived MSCs. Pigs are similar to humans in anatomy,
physiology and immunological responses, and thus may serve as a useful large animal preclinical model to study
potential cellular therapy for human diseases.
Methods: We isolated MSCs from the lungs (L-MSCs) of 4–6-week-old germ-free pigs. We determined the
self-renewal, proliferation and differentiation potential of L-MSCs. We also examined the mechanisms of
immunoregulation by porcine L-MSCs.
Results: MSCs isolated from porcine lungs showed spindle-shaped morphology and proliferated actively in culture.
Porcine L-MSCs expressed mesenchymal markers CD29, CD44, CD90 and CD105 and lacked the expression of
hematopoietic markers CD34 and CD45. These cells were multipotent and differentiated into adipocytes, osteocytes
and epithelial cells. Like human MSCs, L-MSCs possessed immunoregulatory properties and inhibited proliferation of
T cells and interferon-γ and tumor necrosis factor-α production by T cells and dendritic cells, respectively, and
increased the production of T-helper 2 cytokines interleukin (IL)-4 and IL-13 by T cells. L-MSCs induced the
production of prostaglandin E2 (PGE2) in MSC–T cell co-cultures and inhibition of PGE2 significantly restored
(not completely) the immune modulatory effects of L-MSCs.
Conclusions: Here, we demonstrate that MSCs can be isolated from porcine lung and that these cells, similar to
human lung MSCs, possess in vitro proliferation, differentiation and immunomodulatory functions. Thus, these cells
may serve as a model system to evaluate the contribution of lung MSCs in modulating the immune response,
interactions with resident epithelial cells and tissue repair in a pig model of human lung diseases.
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Introduction
Mesenchymal stem (stromal) cells (MSCs) are multipo-
tent cells that were first identified in bone marrow (BM)
as plastic adherent fibroblast cells. Subsequent studies
suggested that MSCs exist in almost all tissues including
the lungs [1, 2]. MSCs express mesenchymal markers
such as CD44, CD73, CD90, and CD105, and are nega-
tive for the expression of hematopoietic markers CD34
and CD45 [3]. These cells are multipotent and are cap-
able of differentiating into multiple cell types including
adipocytes, osteocytes, chondrocytes, neurons, cardio-
myocytes and epithelial cells [4–7].
MSCs possess immunomodulatory properties and in-
hibit inflammation and immunological responses. Further-
more, MSCs express low levels of major histocompatibility
complex molecules and do not express co-stimulatory
molecules such as CD40, CD80 and CD86 that mediate T
activation; hence these cells escape lysis by T cells. Many
reports indicated that MSC-mediated immunosuppressive
effects are due to the release of soluble factors [8]. Due to
their proliferative capacity, differentiation and immunoreg-
ulatory properties, MSCs are attractive as cellular therapy
for inflammatory and autoimmune diseases, and regenera-
tive medicine.
Mice are extensively used as an animal model for hu-
man diseases due to their easy handling. Undoubtedly,
mouse models have contributed immensely to our un-
derstanding of the pathogenesis of human diseases and
in providing useful insights into the mechanisms of stem
cell-mediated beneficial effects for human diseases [9].
However, results obtained from the rodent models are
not always reproducible in humans [10, 11]. In addition,
due to differences in the size and physiology of mouse
and human organs, it is difficult to evaluate the func-
tional consequences of cell therapy in mouse models.
Moreover, the short life span of mice does not allow
evaluation of long-term effects of stem cell therapy.
These differences highlight the need for confirming the
results obtained from mouse models in large animal
models, such as pigs, before testing stem cell therapy in
human clinical trials. Pigs offer several advantages as a
large animal model for stem cell therapy for human con-
ditions/diseases. Similar to humans, pigs are an out-bred
species and they resemble humans in anatomy, physi-
ology, and immune responses [12–17]. Moreover, pigs
are similar to humans in terms of body size and have a
fairly long life span which makes them an ideal large ani-
mal model for cellular therapy [18–22].
In this study, we isolated and characterized MSCs
from the lungs of pigs (L-MSCs). Additionally, we exam-
ined the mechanisms of immunoregulation by L-MSCs
and observed prostaglandin E2 (PGE2) as one of the me-
diator likely involved in the immunomodulatory activity
of L-MSCs. L-MSCs described here are similar to human
L-MSCs in terms of phenotype, differentiation and im-
munoregulation; therefore, these cells will be useful in
elucidating the mechanisms of MSC-mediated thera-
peutic effects in a pig model of human lung diseases.
Methods
Isolation and culture of porcine L-MSCs
Near-term pregnant Landrace-Yorkshire white-Duroc
crossbred sows (Swine herd, The Ohio State University,
Columbus, USA) were delivered by hysterectomy and
piglets were housed in sterile gnotobiotic isolator units
as described previously [23]. The piglets of either sex
were reared and euthanized according to the protocols
approved by the Institutional Laboratory Animal Care
and Use Committee, The Ohio State University. BM and
lungs were harvested from 4–6-week-old germ-free pigs
(n = 6). MSCs from BM were isolated as described earlier
[24, 25] and these cells were included as positive con-
trols for analyzing the expression of mesenchymal
markers on MSCs. Lung tissues were cut into small
pieces (approximately 3–4 cm) and treated with 0.5 mg/
ml collagenase type II (Life Technologies) in Dulbecco’s
modified Eagle’s medium (DMEM) for 1 h at 37 °C with
continuous shaking. The single cell suspensions were
filtered through 70-μm filters (BD, Falcon, USA) and
mononuclear cells were isolated by centrifugation on
Ficoll-Hypaque (GE HealthCare). After washing, cells
were resuspended in DMEM containing 10 % fetal bovine
serum (FBS) and 1 % antibiotics. The cells were seeded in
T-25 cm2 flasks at 1 × 105/cm2. After 2–3 days of incuba-
tion, nonadherent cells were discarded and fresh medium
was added to the cultures. The cells were trypsinized at
confluency using 0.05 % trypsin-EDTA (Gibco) and were
passaged at least 2 times to remove macrophages. MSCs
passaged between 2 and 8 times were used in all the
experiments.
Self-renewal potential of L-MSCs was assessed by col-
ony forming unit-fibroblast (CFU-F) assay as described
previously [24]. Briefly, 100 L-MSCs/well were seeded in
a six-well plate. The cells were incubated at 37 °C for 10
days with fresh media added every 3 days. After 10 days
of incubation, cells were stained with Giemsa stain and
colonies greater than 3 mm were counted.
Cell proliferation assay
Proliferation potential of L-MSCs was determined by
MTT assay as described previously [26]. Ten thousand
cells suspended in 100 μl DMEM were plated in each
well of flat-bottomed 96-well plates. At indicated times,
20 μl MTT (2 mg/ml) was added to each well and cells
were incubated further for 4 h at 37 °C. After the incu-
bation, medium was removed and 100 μl DMSO was
added and plates were incubated for 30 min at 37 °C to
dissolve blue formazan crystals. The absorbance was
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read at 570 nm with a reference filter of 620 nm on a plate
reader (Spectramax; Molecular Device). Cell growth was
measured by plotting optical density (OD) values against
time.
L-MSC phenotyping by flow cytometry
L-MSCs were examined for the expression of mesenchymal
markers (CD29, CD44, CD90 and CD105), hematopoietic
markers (CD34 and CD45), monocyte (CD14) B cell
(CD79β) and swine leucocyte antigen (SLA) I and II by
flow cytometry. BM-MSCs were included as positive con-
trols for comparison. MSCs were stained with the follow-
ing primary antibodies: mouse anti-pig CD29 (IgG1),
mouse anti-pig CD90 (IgG1), mouse anti-pig CD44
(IgG2b, VMRD), mouse anti-pig CD45 (IgM, VMRD),
mouse anti-pig/human CD105 (IgG2a, GeneTex), Mouse
anti pig CD14 (IgG2b, Serotec), rat anti-pig CD79b (IgG1,
Serotec), FITC Mouse Anti-Human CD34 (IgG1, BD Bio-
sciences), SLA-I (IgG2a, VMRD), SLA-II (IgG2b, VMRD;
IgG2b FITC, Serotec) for 20 min at 4 ° C. After washing,
cells were stained with appropriate secondary antibodies.
Cells were acquired using a C6 flow cytometer (BD Accuri
Cytometers) and analyzed using CFlow® plus Software
(Accuri) [27].
Detection of octamer-binding transcription factor 4
expression on L-MSCs
L-MSCs were examined for the expression of pluripo-
tency (octamer-binding transcription factor 4; Oct4)
marker by immunofluorescence assay (IFA) [28, 29].
Porcine MSCs have been shown to express Oct4; there-
fore, BM-MSCs were included as positive control [30,
31]. The cells were fixed in a mixture of methanol:ace-
tone (1:1) for 3 min at room temperature followed by
blocking with 3 % bovine serum albumin for 30 min.
Cells were incubated at 4 °C overnight with rabbit anti-
human Oct4 (Santa Cruz Biotechnology). Next, cells
were incubated with FITC-labeled secondary antibody
for 45 min at room temperature. Cell nuclei were
stained with 4′,6-diamidino-2-phenylindole (DAPI).
In vitro differentiation of L-MSCs into adipocytes and
osteocytes
Differentiation of L-MSCs into adipocytes and osteo-
cytes was examined as described previously by Khatri et
al. [24]. In brief, for adipogenesis, L-MSCs at 70–80 %
confluence were cultured in DMEM supplemented with
10 % FBS, 1 μM dexamethasone, 10 μg/ml insulin, and
0.2 mM indomethacin for 21 days. The medium was
refreshed every 3–4 days. Adipogenic differentiation of
L-MSCs was assessed by Oil Red O staining.
For osteogenic differentiation, cells were cultured for
21 days in DMEM containing 10 % FBS, 100 nM dexa-
methasone, 10 mM β-glycerophosphate (Sigma-
Aldrich), and 0.05 mM L-ascorbic acid-2-phosphate
(Sigma-Aldrich). Cells were fed with fresh medium
every 3–4 days. Calcium deposition indicative of osteo-
genesis was detected by Von Kossa staining [24].
In vitro differentiation of MSCs into epithelial phenotypes
L-MSCs were cultured in epithelial growth medium con-
taining bovine pituitary extract (70 μg/ml), human epi-
dermal growth factor (5 ng/ml), insulin (5 μg/ml), and
hydrocortisone (0.5 μg/ml) (MEGM, Lonza, Walkers-
ville, MD, USA) for 10 days. The expression of epithelial
markers, pancytokeratin and cytokeratin-18 was de-
tected by IFA using mouse anti-human pancytokeratin
and anti-human cytokeratin-18 (Sigma) primary and ap-
propriate secondary antibodies by IFA [28, 29].
Immunomodulation by L-MSCs
L-MSCs were isolated from 4–6-week-old germ-free pigs
(n = 6) as described above. Peripheral blood mono-
nuclear cells (PBMCs) and dendritic cells (DCs) were
isolated from conventional 4–6-week-old specific
pathogen-free Large White-Duroc crossbred pigs (n = 3)
and were used in L-MSC–PBMC–DC co-culture
experiments.
MSC–DC co-cultures
BM-DCs were isolated from 4–6-week-old pigs as de-
scribed previously with minor modifications [32]. Briefly,
BM mononuclear cells were cultured in RPMI-1640
medium supplemented with 10 % FBS, 1 % antibiotics
and 10 ng/ml each of recombinant swine granulocyte
macrophage colony-stimulating factor and recombinant
swine interleukin (IL)-4 for 3 days. DCs were identified
as nonadherent cells showing dendrites and by the ex-
pression of SwC3a and SLA-II. DCs cultured in the
presence or absence of MSCs were stimulated with lipo-
polysaccharide (LPS; 100 ng/ml) overnight. The levels of
tumor necrosis factor (TNF)-α in culture supernatants
were measured by enzyme-linked immunosorbent assay
(ELISA) [27].
T-cell proliferation and Th1 and Th2 cytokine detection
T-cell proliferation was analyzed by staining the cells
with carboxyfluorescein diacetate succinimidyl ester
(CFSE). PBMCs were isolated from 4–6-week-old SPF
pigs by Ficoll-Hypaque gradient separation [27]. PBMCs
were labeled with 5 μM CFSE for 5 min at room
temperature. After washing, the cells were suspended in
RPMI 1640 medium supplemented with 10 % FBS and 1
% antibiotics (Gibco) in a 24-well plate in the presence
or absence of MSCs (MSC to PBMC ratio 1:10). The cul-
tures were stimulated with mitogen (phytohemagglutinin
(PHA); 5 μg/ml) and incubated for 72 h at 37 °C. Cell pro-
liferation was analyzed by flow cytometry (Accuri).
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For the measurement of cytokines in MSC–PBMC co-
cultures, PBMCs were stimulated with PHA (5 μg/ml) in
the presence or absence of L-MSCs. At 24 h, superna-
tants were collected and interferon (IFN)-γ (T helper 1;
Th1), IL-4 and IL-13 (Th2) levels were determined by
ELISA as described previously [27].
The levels for IL-6 (proinflammatory), IL-10 (anti-
inflammatory) and PGE2 in the cell-culture supernatant
of MSC–PBMC co-cultures were also determined by
ELISA and enzyme immunoassay (Cayman chemicals,
AnnArbor, MI), respectively.
Induction of T regulatory cells in MSC–T cell co-cultures
PBMCs (1 × 106) were cultured in the presence or absence
of L-MSCs (1 × 105) for 48 h at 37 °C. Induction of T
regulatory cells (Tregs) in L-MSC–PBMC co-cultures was
analyzed by examining the expression of regulatory T-cell
marker (FoxP3) on CD4 cells by flow cytometry as de-
scribed previously [33]. Briefly, cells isolated from co-
cultures were stained with CD4-PE. Cells were then
fixed and permeabilized with Cytofix/Cytoperm buffer
(BD Biosciences) according to manufacturer’s instruc-
tions followed by staining with rat anti-mouse Foxp3-
FITC Ab (clone FJK-16 s; eBioscience). Appropriate iso-
type controls were also included during staining. Cells
were acquired using a C6 flow cytometer (BD Accuri
Cytometers) and analyzed using CFlow® plus Software
(Accuri) [27].
Effect of PGE2 inhibition on T-cell proliferation
To examine the effect of PGE2 inhibitor on T-cell prolif-
eration, L-MSCs were incubated overnight in the pres-
ence or absence of PGE2 inhibitor NS-398 (Cayman
chemicals) [34]. PBMCs isolated from out-bred conven-
tional pigs were stained with CFSE. PBMCs were then
added to MSC cultures (1:10 ratio) and both cell types
were cultured in media containing NS-398 (5 μM).
PBMCs cultured in the presence or absence of MSCs
were stimulated with PHA for 72 h. Cell proliferation
was analyzed by flow cytometry. We also examined the
effect of PGE2 inhibition on TNF-α and IFN-γ produc-
tion by DCs and PBMCs, respectively. L-MSCs were cul-
tured overnight in medium with or without NS-398.
DCs or PBMCs suspended in RPMI medium with or
without NS-398 were added to the L-MSCs. MSC/DC
cultures were stimulated with LPS (100 ng/mL) and
MSCs/PBMC cultures were stimulated with PHA (5 μg/
mL). After 24-h incubation, TNF-α production in MSC/
DC and IFN-γ in MSC/T cell co-cultures was deter-
mined by ELISA.
Fig. 1 Characteristics of porcine L-MSCs. a Morphology of porcine L-MSCs. Porcine L-MSCs exhibit characteristic fibroblast-like morphology. b Colony
forming unit-fibroblast assay. L-MSCs were cultured at 100 cells/well in a six-well plate. Single cells proliferated and formed colonies as shown by
Giemsa staining. c In vitro proliferation potential of L-MSCs. L-MSCs were suspended in DMEM containing 10 % FBS and cultured in a 96-well plate. At
indicated intervals, cell proliferation was measured by MTT assay. Optical density (OD) values at each time point are mean ± SD of L-MSCs isolated from
three different pigs and cultured in triplicate wells
Khatri et al. Stem Cell Research & Therapy  (2015) 6:222 Page 4 of 11
Statistical analysis
Data were expressed as the mean ± SD from three inde-
pendent experiments/three or more pigs. A two-tailed
Student t-test or one-way analysis of variance followed
by Tukey test was used to compare significant differ-
ences between groups. A P value <0.05 was considered
to be statistically significant.
Results
Isolation of plastic-adherent porcine L-MSCs
MSCs were successfully isolated from the lungs of all six
pigs. These MSCs showed characteristic features of
MSCs, such as adherence to plastic surface and fibroblast-
like morphology (Fig. 1a).
One important characteristic of MSCs is their ability
to self-renew and proliferate. The self-renewal potential
of MSCs was assessed by CFU-F assay. One hundred L-
MSCs cultured in each well of a six-well plate formed
28 ± 8 (n = 6) colonies indicating their self-renewal abil-
ity (Fig. 1b). L-MSCs possessed high in vitro prolifera-
tion capacity as shown in Fig. 1c.
Porcine L-MSCs express mesenchymal and pluripotency
markers
Colony-expanded L-MSCs and BM-MSCs were exam-
ined for the expression of mesenchymal markers by flow
cytometry. BM- and L-MSCs showed the expression of
CD29, CD44, CD 90 and CD105 but were negative for
CD34, CD45, CD14 and CD79β suggesting the mesen-
chymal lineage of these cells (Fig. 2a and b ). These cells
also expressed moderate levels of SLA-1 but not SLA-II
(Fig. 2a and b ).
Fig. 2 Phenotype analysis of porcine L-MSCs and expression of pluripotency markers. Porcine (a) BM-MSCs and (b) L-MSCs were detached by
trypsinization and single cell suspension was examined for the expression of mesenchymal markers (CD29, CD44 CD90 and CD105), hematopoietic
(CD34 and CD45), CD14, CD79β, SLA-I and SLA-II by flow cytometry. Black line isotype control, red line antibody staining. (c) Expression of Oct4 on
L-MSCs. L-MSCs were examined for the expression of the pluripotency marker, Oct4, by IFA. BM-MSCs were included as positive control. BM-MSC Bone
marrow mesenchymal stem cell, L-MSC Lung mesenchymal stem cell, SLA Swine leucocyte antigen
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L-MSCs were also examined for the expression of the
pluripotency marker Oct4 (Fig. 2c). The expression of
Oct4 was mainly detected in the cell nuclei of L-MSCs.
Porcine L-MSCs can differentiate into adipocytes,
osteocytes and epithelial cells
MSCs from BM and other anatomical locations demon-
strate mutilineage differentiation potential. L-MSCs also
demonstrated mutilineage differentiation potential.
L-MSCs when cultured in adipocyte induction media
for 21 days differentiated into adipocytes. Differentiated
cells contained multiple lipid vacuoles as demonstrated
by staining with Oil Red O (Fig. 3a). Incubation of L-
MSCs in osteogenic media for 3 weeks demonstrated
tightly packed nodule-like structures. Calcium depos-
ition in differentiated cells was detected by Von Kossa
staining (Fig. 3c).
L-MSCs also differentiated into epithelial cells. L-
MSCs cultured in epithelial cell differentiation media for
10 days exhibited cuboidal-like morphology (Fig. 3e) and
positive staining for epithelial cell markers pancytokera-
tin and cytokeratin-18 (Fig. 3g and i).
Immunomodulation by L-MSCs
L-MSCs inhibit TNF-α secretion by DCs
L-MSCs were co-cultured with BM-derived DCs at a ra-
tio of 1:10 and stimulated with LPS overnight. Data are
expressed as percent change in TNF-α production in
DCs in the presence or absence of MSCs (Fig. 4). There
was more than a 50 % decrease in TNF-α production in
DC-MSC co-cultures as compared to DCs alone. How-
ever, these differences did not reach a significant level
due to large variations in the levels of TNF-α production
between individual pigs. L-MSCs alone did not produce
detectable levels of TNF-α.
L-MSCs suppress T-cell proliferation
Previous reports have shown that MSCs suppress T-cell
proliferation [34–36]. Therefore, we examined the effect
of the L-MSCs on proliferation of T cells. In vitro ex-
panded L-MSCs from three different germ-free pigs were
co-cultured with PBMCs isolated from three pigs. L-
MSCs were highly immunosuppressive and significantly
Fig. 3 Differentiation potential of porcine L-MSCs. a Adipocyte differentiation. L-MSCs when cultured in adipogenic medium for 21 days showed
lipid droplets in the cytoplasm of differentiated cells. b No adipocyte differentiation was detected in cells cultured in DMEM. c Osteocyte differentiation.
L-MSCs cultured in osteogenic medium for 21 days showed calcium deposition as detected by Von Kossa staining. d No osteogenic differentiation
was observed in cells cultured in DMEM. e–h Epithelial differentiation. L-MSCs cultured in epithelial differentiation medium for 10 days exhibited
cuboidal morphology (e) and were found to express epithelial markers pan-cytokeratin (g) and cytokeratin-18 (i) whereas L-MSCs cultured in
DMEM displayed normal spindle-shaped morphology (f), and expression of pan-cytokeratin (h) and cytokeratin-18 (j) was not detected on
undifferentiated L-MSCs
Fig. 4 L-MSCs suppress TNF-α secretion by DCs. Porcine BM-DCs
were cultured in the presence or absence of L-MSCs and stimulated
with LPS overnight. TNF-α production in culture supernatants was
determined by ELISA. Presence of L-MSCs in the culture caused
more than 50 % suppression in TNF-α production by LPS-stimulated
DCs. The data are expressed as % change in TNF-α production
(TNF-α produced by LPS-stimulated DCs was considered as 100 %).
Each bar represents mean percent change ± SD in TNF-α levels from
three independent experiments. *P < 0.05. DC Dendritic cell, MSC
Mesenchymal stem cell, TNF tumor necrosis factor
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(P < 0.05) inhibited PHA-induced T-cell proliferation
(Fig. 5a).
Next we examined whether MSCs modulate the cyto-
kine secretion by mitogen-stimulated PBMCs. PBMCs
stimulated with PHA produced significant amounts of
IFN-γ. However, in the presence of L-MSCs, there was a
significant (P < 0.05) decrease in IFN-γ production and
an increase in IL-4 and IL-13 production by stimulated
PBMCs (Fig. 5b). These data suggest that MSCs directed
the T-cell response towards the Th2 phenotype.
L-MSC–PBMC co-cultures produce cytokines
MSCs isolated from humans have been shown to modu-
late innate and adaptive immune cell functions by the se-
cretion of soluble factors [37–39]. We detected the
constitutive expression of IL-6 and PGE2 in L-MSC cul-
ture supernatants. L-MSCs also produced small quantities
of IL-10. However, when PBMCs were added to L-MSCs
cultures, a significant increase (P < 0.05) in levels of these
factors was observed (Fig. 6a).
We detected significant levels of IL-10 in MSC-PBMC
co-cultures. Therefore, we wanted to see whether L-MSCs
induce the induction of Tregs. There was a significant
(P < 0.05) increase in the proportion of Tregs (FoxP3 ex-
pressing CD4 cells) when PBMCs were co-cultured with
L-MSCs (Fig. 6b).
Inhibition of PGE2 restores partial but significant T-cell
proliferation and IFN-γ and TNF-α production
In previous studies conducted with human BM- and L-
MSCs, PGE2 was found to modulate immune cell func-
tions [34, 35]. Similar to these studies, we also detected
PGE2 in L-MSC–PBMC co-cultures. We used NS-398, a
PGE2 synthesis inhibitor, to examine whether PGE2 reg-
ulates the immunomodulatory activity of L-MSCs. The
blockade of PGE2 synthesis resulted in a significant in-
crease (P < 0.05) in the proportion of mitogen-stimulated
proliferating cells (Fig. 7a and b). Furthermore, inhib-
ition of PGE2 secretion also resulted in a significant in-
crease (P < 0.05) in TNF-α and IFN-γ production by
Fig. 5 L-MSCs suppress mitogen-stimulated T-cell proliferation and Th1 cytokine secretion and promote Th2 cytokine secretion by T cells.
a L-MSCs inhibit mitogen-stimulated T-cell proliferation. L-MSCs (1 × 105/well) were plated in a 24-well plate overnight. CFSE-labeled PBMCs
(1 × 106/well) isolated from unrelated pigs were added to L-MSC cultures and stimulated with PHA (5 μg/ml). L-MSC–PBMC co-cultures were
incubated for 72 h at 37 °C. The cell proliferation was analyzed by flow cytometry. A representative flow diagram is shown. b Data are presented
as % change in proliferating T cells relative to PHA-stimulated PBMCs without MSC group (PBMCs stimulated with PHA were considered as 100
%). The experiment was performed with L-MSCs/PBMCs isolated from three different pig pairs. *P < 0.05, versus the no MSC group. c L-MSCs
inhibit Th1 and enhance Th2 cytokine production by T cells. PBMCs were stimulated with PHA in the presence or absence of L-MSCs for 24 h.
After the incubation, the supernatants were collected and examined for Th1 (IFN-γ) and Th2 (IL-4 and IL-13) cytokine production by ELISA. Data
are expressed as % change in IFN-γ, IL-4 and IL-13 production in L-MSC/PBMC co-cultures relative to PHA-stimulated PBMCs (PBMCs stimulated
with PHA considered as 100 %). The values are means ± SD. *P < 0.05. The experiments were performed with L-MSCs and PBMCs isolated from
three germ-free and SPF pigs respectively. IFN Interferon, IL Interleukin, MSC Mesenchymal stem cell
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DCs and T cells, respectively (Fig. 7c and d). These find-
ings indicated that, similar to human MSCs, porcine L-
MSC-produced PGE2 is likely involved in the regulation
of MSC-mediated immunomodulatory effects.
Discussion
In this study, we isolated mesenchymal cells from the
lungs of pigs. The isolated cells expressed transcription
factors Oct4 and surface mesenchymal markers but
lacked the expression of hematopoietic stem cell markers.
L-MSCs also differentiated into adipocytes, osteocytes and
epithelial cells. Importantly, L-MSCs showed immuno-
modulatory properties and inhibited TNF-α production
by DCs and inhibited IFN-γ production and T-cell prolif-
eration. Mechanistically, we found that PGE2 was partly
involved in mediating the immunomodulatory activity of
L-MSCs on DCs and T cells.
Multipotent L-MSCs have been isolated from human
lungs [2, 40]. Similar to human L-MSCs, porcine L-
MSCs expressed mesenchymal lineage markers whereas
hematopoietic markers were not expressed on either
human or porcine L-MSCs [2]. Isolated L-MSCs, like
their human counterparts, were multipotent and differ-
entiated into adipocytes, osteocytes and epithelial cells
[2, 40]. Additionally, we detected the expression of Oct4
in L-MSCs. Oct4 regulates self-renewal and pluripo-
tency of MSCs [41]. The expression of Oct4 in L-MSCs
may be involved in regulating the pluripotency and self-
renewal of these cells.
Although we have not directly compared the epithelial
differentiation potential of lung- and BM-derived MSCs,
it is likely that L-MSCs may have greater capacity to dif-
ferentiate into lung epithelial cells. Tissue origin is
known to govern the differentiation of MSCs. Recently,
it was demonstrated that, compared to BM-MSCs, L-
MSCs readily differentiated into epithelial cells [40]. In
the current study also, L-MSCs under in vitro conditions
differentiated into epithelial cells. Many studies have
previously shown that transplantation of BM- and um-
bilical cord-derived MSCs differentiated into lung epi-
thelial cells in a lung injury model [42–44]. In future in
vivo studies, we will examine the differentiation and tis-
sue repair potential of L-MSCs in lung injury or disease
models in pigs.
In this study, presence of L-MSCs in DC cultures
caused suppression of TNF-α secretion. Similar to our
observations, human BM-MSCs also inhibited the secre-
tion of TNF-α in MSC–DC co-cultures. Although, we
Fig. 6 L-MSCs secrete soluble factors. a L-MSCs were co-cultured with PBMCs (1:10 ratio) for 24 h. After the incubation, levels of IL-6, IL-10 and
PGE2 in culture supernatants were measured by ELISA. Data are presented as mean ± SD of IL-6, IL-10 and PGE2 levels in pg/ml in MSC–PBMC
co-cultures, each cell type isolated from three different pig pairs. *P < 0.05. b MSCs promote the induction of Tregs. PBMCs (1 × 106) were cultured
in the presence or absence of L-MSCs (1 × 105) for 48 h. Expression of regulatory T-cell marker (FoxP3) on CD4 cells was analyzed by flow cytometry. In
the presence of L-MSCs, an increased proportion of Tregs was induced. Data are presented as mean ± SD proportion of CD4+FoxP3+cells. L-MSCs and
PBMCs were isolated from three different pigs. IL Interleukin, MSC Mesenchymal stem cell, PBMC Peripheral blood mononuclear cell, PGE2 Prostaglansin
E2, Tregs T regulatory cells
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have not analyzed the effects of L-MSCs on expression
of co-stimulatory molecules on DCs in this study, earlier
studies have shown that MSCs suppress the maturation
of DCs, thus decreasing their ability to cause expansion
of T cells [45, 46].
Several studies conducted with human- and mouse-
derived MSCs have shown that Tregs are induced in
MSC–T cell co-cultures [34, 36]. In this study, we also
observed an increase in the proportion of FoxP3 ex-
pressing CD4 T cells in L-MSC–PBMC co-cultures.
However, we observed lower expression of T-cell activa-
tion marker, CD25, on T cells co-cultured with MSCs
(data not shown). Similar to our observations, Le Blanc
et al [47] and Batten et al [36] also showed the inhibition
of CD25 expression on T cells co-cultured with MSCs.
Two main subsets of Tregs have been defined: CD4
+CD25hiFoxP3+ and CD4+CD25loFoxP3+. There is evi-
dence that regulatory T-cell function of Tregs is associ-
ated with the expression of FoxP3, not the CD25
expression [48].
Fig. 7 Immunomodulatory effects of L-MSCs are mediated via secretion of PGE2. a L-MSCs were cultured in media containing the PGE2 inhibitor
NS-398 overnight. CFSE-labeled PBMCs from unrelated pigs were co-cultured with MSCs in media containing PGE2 inhibitor NS-398. The cultures
were stimulated with PHA (5 μg/ml). After 72 h, cell proliferation was analyzed by flow cytometry. A representative flow diagram is shown.
b Percent change in cell proliferation in the presence or absence of PGE2 inhibitor (cultures of PBMCs only stimulated with PHA were considered
as 100 %). Data are presented as % change in cell proliferation (mean ± SD) from MSCs/PBMCs isolated from three unrelated pig pairs. *P < 0.05.
c Overnight cultures of L-MSCs and DCs were co-cultured with or without NS-398 and stimulated with LPS. TNF-α secretion in culture supernatants
was detected by ELISA. Addition of PGE2 inhibitor resulted in a significant increase (P < 0.05) in TNF-α levels. Data are presented as mean ± SD of
TNF-α levels in MSCs/DCs isolated from three unrelated pig pairs. *P < 0.05. d L-MSCs and PBMCs were co-cultured in media with or without NS-398.
The cultures were stimulated with PHA and incubated for 24 h. IFN-γ production in culture supernatants was measured by ELISA. There was an
increase in IFN-γ levels in cultures incubated with NS-398 PGE2. Data are presented as mean ± SD of IFN-γ levels in MSC/PBMC co-cultures isolated
from three unrelated pig pairs. *P < 0.05. CFSE Carboxyfluorescein diacetate succinimidyl ester, DC Dendritic cell, IFN Interferon, MSC Mesenchymal stem
cell, TNF Tumor necrosis factor
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MSCs modulate the functions of immune cells through
the secretion of soluble factors [38]. In previous studies,
Jarvinen et al. [35] have shown that lung-derived human
MSCs modulate immune responses by production of
PGE2. In this study, we examined whether PGE2 is in-
volved in L-MSC-mediated suppression of porcine DCs
and T-cell functions. Porcine L-MSCs produced PGE2,
and the addition of T cells to MSC cultures resulted in a
significant increase in PGE2 production. Blocking of
PGE2 secretion by an inhibitor significantly restored T-
cell proliferation and IFN-γ and TNF-α production. How-
ever, in our studies, the restoration of T-cell proliferation
and IFN-γ production by T cells and TNF-α production
by DCs after PGE2 blockage was not complete suggesting
that other soluble factors may also be involved in MSC-
mediated inhibition of T cells. Further studies are required
to understand completely the mechanisms of T-cell inhib-
ition by L-MSCs and to identify additional soluble factors
that may have immunomodulatory activity on innate and
adaptive immune cells.
Conclusions
In conclusion, for the first time we isolated MSCs from
the lungs of pigs. Porcine L-MSCs showed proliferation
and multilineage differentiation and they possessed po-
tent immunomodulatory activity. Identification and
characterization of these cells will help in understanding
the mechanisms of MSC-mediated attenuation of disease
and lung repair in the clinically relevant pig model of
human respiratory diseases.
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